Pharmaceuticals, Biotechnology and Life Sciences
Participation certificates (Partizipationsscheine) with a nominal value of CHF 0.001 each will replace the non-voting equity securities (Genussscheine). Reduction of…
Preclinical-stage biotech company explores digital asset treasury opportunities to enhance capital efficiency while maintaining core focus on immunotherapy innovationLA PALMA,…
Aggregated presentation by day and by market Statement of transactions in own shares from July 14th to July 18th 2025…
New Taipei City, Taiwan, July 22, 2025 (GLOBE NEWSWIRE) — Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a…
Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation for continued carePresentations on tau…
CARLSBAD, Calif., July 21, 2025 (GLOBE NEWSWIRE) — Natural Alternatives International, Inc. (“NAI”) (NASDAQ:NAII), a leading formulator, manufacturer and marketer…
MENLO PARK, Calif., July 21, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly…
Data supports further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma. SAN DIEGO, Calif.,…
Activity Report for Quarter Ended June 30, 2025 (Appendix 4C)NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO;…
Funding in the amount of $2.0M from Japanese strategic investor, in the form of common equity PIPE with warrants. New…